Tag: ESMO2025

Research Unveiled at ESMO 2025: MSK’s Groundbreaking Advances in Lung, Pancreatic, and Solid Tumor Cancer Treatments

Discover the latest cancer research breakthroughs from Memorial Sloan Kettering (MSK) presented at ESMO 2025, including new therapies for lung, pancreatic, and mismatch repair–deficient solid tumors. Explore the promising clinical results that may redefine future cancer care.